When it comes to weight loss, semaglutide has a clear edge over liraglutide
No QTc prolongation with semaglutide: a thorough QT study in healthy subjects
Kopp K, Glotfelty E, Li Y, et al (2023) Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment
GLP-1 agonists, such as liraglutide and semaglutide, are increasingly used in medical weight loss due to their ability to mimic the natural hormone glucagon-like peptide-1, which is, for the most part, responsible for regulating appetite and food intake
Medication access concerns drive many transitions, and people report mixed experiences depending on their sources